Front Row Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-65
Closed 1035
2020
Q2
$0 Hold
65
﹤0.01% 1025
2020
Q1
$0 Hold
65
﹤0.01% 1064
2019
Q4
$1K Hold
65
﹤0.01% 887
2019
Q3
$1K Hold
65
﹤0.01% 895
2019
Q2
$1K Hold
65
﹤0.01% 994
2019
Q1
$1K Hold
65
﹤0.01% 1018
2018
Q4
$0 Hold
65
﹤0.01% 1101
2018
Q3
$0 Hold
65
﹤0.01% 1033
2018
Q2
$1 Hold
65
﹤0.01% 987
2018
Q1
$1K Hold
65
﹤0.01% 918
2017
Q4
$1K Buy
+65
New +$1.26K ﹤0.01% 816

Other funds holding DBD

Front Row Advisors's DBD Position: Q3 2020 in Review

Front Row Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2020, closing a stake of 65 shares.

Front Row Advisors first reported a position in DBD in Q4 2017 and held it in 11 quarters. The position peaked at $1K in Q4 2019. 177 funds tracked by Wall St. Rank hold DBD as of Q3 2020.

  • Front Row Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q3 2020 after selling out during the quarter.
  • Front Row Advisors sold 65 Diebold Nixdorf Incorporated shares in Q3 2020.
  • Front Row Advisors first reported a position in Diebold Nixdorf Incorporated in Q4 2017 and held it in 11 quarters.
  • Front Row Advisors's Diebold Nixdorf Incorporated position peaked at $1K in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2020.

Based on Front Row Advisors's 13F filing for Q3 2020, filed 30 Nov 2020.